Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.46M 19.06M 17.51M 33.1M 2.25B 33.53M 224M 88.05M 1.12B 88.72M 86.77M 3.72B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.53M 34.04M 31.26M 59.11M 4.02B 59.87M 401M 157M 2B 158M 155M 6.63B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
17-08-04 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
17-05-15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
17-02-13 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
16-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
16-10-04 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16-05-16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
16-02-08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
16-02-01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
15-12-10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
15-12-04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
15-12-01 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
15-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
15-10-12 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+20.00%
Current month+20.00%
1 month+2.44%
3 months-19.23%
6 months-6.67%
Current year+27.27%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.73
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+20.00%-36.36%+100.00% 1.33M
-1.87%+4.05%+22.58%+442.96% 2.16B
+3.94%+21.26%-29.67%-53.83% 1.93B
+0.37%-3.46% - - 1.79B
-0.45%+3.23%+81.51%+480.03% 1.33B
-3.19%+8.59%-43.41%+29.26% 1.29B
+0.80%+0.88%+332.98%+921.97% 1.08B
+3.91%+6.81%+60.35%+44.83% 1.03B
+7.02%+30.23%+19.84%+64.15% 887M
+9.99%+61.06%+35.96%-38.09% 525M
Average +2.05%+9.52%+49.31%+221.25% 1.2B
Weighted average by Cap. +1.32%+7.65%+49.13%+255.05%

Financials

2015 2016
Net sales 25.48M 22.06M 20.56M 18.88M 35.7M 2.43B 36.17M 242M 94.97M 1.21B 95.69M 93.58M 4.01B 32.33M 27.99M 26.09M 23.96M 45.3M 3.08B 45.89M 307M 120M 1.54B 121M 119M 5.08B
Net income 5.49M 4.76M 4.43M 4.07M 7.7M 524M 7.8M 52.21M 20.48M 261M 20.63M 20.18M 864M 2.06M 1.78M 1.66M 1.53M 2.89M 197M 2.93M 19.58M 7.68M 97.95M 7.74M 7.57M 324M
Net Debt 24.8M 21.48M 20.01M 18.38M 34.75M 2.37B 35.2M 236M 92.45M 1.18B 93.15M 91.1M 3.9B 18.56M 16.07M 14.98M 13.75M 26M 1.77B 26.34M 176M 69.18M 882M 69.7M 68.16M 2.92B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
26-07-27 US$0.003500 -.--% 70,000
  1. Stock Market
  2. Stocks
  3. AOXG Stock